Cargando…
Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care
BACKGROUND: Fractional exhaled nitric oxide (FeNO) is a surrogate marker of eosinophilic airway inflammation and good predictor of corticosteroid response. AIM: To evaluate how FeNO is being used to guide primary care asthma management in the United Kingdom (UK) with a view to devising practical alg...
Autores principales: | Price, David, Ryan, Dermot, Burden, Annie, Von Ziegenweidt, Julie, Gould, Shuna, Freeman, Daryl, Gruffydd-Jones, Kevin, Copland, Anne, Godley, Clifford, Chisholm, Alison, Thomas, Mike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826517/ https://www.ncbi.nlm.nih.gov/pubmed/24195942 http://dx.doi.org/10.1186/2045-7022-3-37 |
Ejemplares similares
-
Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes
por: Gemicioglu, Bilun, et al.
Publicado: (2014) -
Fractional exhaled nitric oxide (FeNO) measurement in asthma and rhinitis
por: Gevorgyan, Artur, et al.
Publicado: (2013) -
Fractional exhaled nitric oxide (FeNO): the future of asthma care?
por: Wang, Kay, et al.
Publicado: (2023) -
296 The Relationship of Fractional Exhaled Nitric Oxide (FeNO) and Acute Exacerbation of Childhood Asthma
por: Rha, Yeong Ho, et al.
Publicado: (2012) -
The Effect of Adiposity Markers on Fractional Exhaled Nitric Oxide (FeNO) and Pulmonary Function Measurements
por: Al Khathlan, Noor, et al.
Publicado: (2020)